Sep 1, 2026 04:04PM
Sep 1, 2026 06:59AM
Aug 31, 2026 08:51AM
Aug 31, 2026 06:49AM
Aug 27, 2026 06:55AM
Aug 25, 2026 04:01PM
Aug 19, 2026 05:29AM BMO Capital Starts Ascendis Pharma (ASND) at Outperform
Aug 13, 2026 04:08PM
Aug 13, 2026 04:03PM
Aug 13, 2026 07:41AM
Aug 6, 2026 08:01AM
Jul 14, 2026 06:03AM
Jun 15, 2026 07:07AM
Jun 9, 2026 06:51AM Oppenheimer Reiterates Outperform Rating on Ascendis Pharma (ASND)
Jun 3, 2026 04:30AM
May 7, 2026 07:40AM
May 6, 2026 04:01PM
Apr 15, 2026 04:36PM
Apr 8, 2026 08:02AM
Apr 6, 2026 04:01PM
Apr 1, 2026 07:03AM Ascendis Pharma (ASND) Reiterated at Overweight by Cantor Fitzgerald After Model Update
Mar 18, 2026 09:21AM
Mar 17, 2026 08:32AM
Mar 5, 2026 04:18PM
Mar 4, 2026 03:22PM
Mar 2, 2026 03:49PM
Mar 2, 2026 03:21PM
Mar 2, 2026 12:56PM Morgan Stanley on Ascendis Pharma (ASND): 'we view Yuviwel’s approval as a positive inflection for Ascendis'
Mar 2, 2026 10:59AM
Mar 2, 2026 10:38AM
Mar 2, 2026 10:03AM
Mar 2, 2026 09:19AM
Mar 2, 2026 04:55AM
Feb 23, 2026 08:58AM
Feb 12, 2026 01:54PM Ascendis Pharma (ASND) PT Raised to $300 at Cantor Fitzgerald
Feb 12, 2026 10:03AM
Feb 12, 2026 07:41AM
Feb 11, 2026 04:01PM
Jan 22, 2026 11:56AM
Jan 20, 2026 05:30AM
Jan 12, 2026 08:26AM
Jan 12, 2026 08:18AM Ascendis Pharma (ASND) Reiterated at Overweight by Cantor Fitzgerald
Jan 9, 2026 07:10AM
Jan 8, 2026 04:04PM
Jan 8, 2026 08:49AM
Jan 7, 2026 09:13AM
Dec 12, 2025 03:22PM
Nov 26, 2025 07:00AM
Nov 26, 2025 06:48AM Ascendis Pharma's (ASND) PDUFA Disclosure Removes Near-Term Stock Upside - Stifel
Nov 24, 2025 08:53AM

443,846 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All